Cas:852180-56-4 N-[(4-piperidin-1-ylphenyl)methyl]propan-1-amine manufacturer & supplier

We serve Chemical Name:N-[(4-piperidin-1-ylphenyl)methyl]propan-1-amine CAS:852180-56-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-[(4-piperidin-1-ylphenyl)methyl]propan-1-amine

Chemical Name:N-[(4-piperidin-1-ylphenyl)methyl]propan-1-amine
CAS.NO:852180-56-4
Synonyms:N-(4-Piperidin-1-ylbenzyl)-N-Propylamine;[(4-piperidylphenyl)methyl]propylamine
Molecular Formula:C15H24N2
Molecular Weight:232.36400
HS Code:2933399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:362ºC at 760 mmHg
Density:0.983g/cm3
Index of Refraction:1.534
PSA:15.27000
Exact Mass:232.19400
LogP:3.63240

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like N-(4-Piperidin-1-ylbenzyl)-N-Propylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,[(4-piperidylphenyl)methyl]propylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,[(4-piperidylphenyl)methyl]propylamine Use and application,N-(4-Piperidin-1-ylbenzyl)-N-Propylamine technical grade,usp/ep/jp grade.


Related News: Tánaiste and Minister for Enterprise, Trade and Employment, Leo Varadkar TD welcomed the announcement, saying: “I’m really pleased that Ballina will play such an important role in the production of COVID-19 vaccines, which have saved millions of lives around the world. 2-[hydroxy-(1-oxido-4-oxoquinoxalin-4-ium-2-yl)methyl]-4-methoxyphenol manufacturers In the US, however, ODAC in April voted to keep alive the accelerated approval for Tecentriq plus Abraxane (nab-paclitaxel) in mTNBC while additional confirmatory trials are ongoing. Disiloxane, 1-butyl-3-ethenyl-1,1,3,3-tetramethyl- suppliers When these modified cells are given back to the patient, they are transported in the bloodstream to the bone marrow where they start to make healthy red blood cells that produce beta-globin. The effects of Zynteglo are expected to last for the patient’s lifetime. 2-fluoro-5-iodo-thiophene vendor & factory AstraZeneca’s deal, the largest struck last year, is all part of CEO Pascal Soriot’s mission to hit $40 billion in global sales by 2023. ,In the US, however, ODAC in April voted to keep alive the accelerated approval for Tecentriq plus Abraxane (nab-paclitaxel) in mTNBC while additional confirmatory trials are ongoing.